Evidence map›Paper›PMID 31631586›Full record

Observational studyAnnals of clinical and translational neurology2019

Impaired cognition predicts the risk of hospitalization and death in cirrhosis.

Minjee Kim, Eric M Liotta, Phyllis C Zee, Daniel R Ganger, Daniela P Ladner, Ameeta Karmarkar, John D Peipert, Farzaneh A Sorond, Shyam Prabhakaran, Kathryn J Reid and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Annals of clinical and translational neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Minjee KimDivision of Stroke and Neurocritical Care, Department of Neurology, Northwestern University, Chicago, Illinois.ORCID 0000-0002-2720-1940
Eric M LiottaDivision of Stroke and Neurocritical Care, Department of Neurology, Northwestern University, Chicago, Illinois.
Phyllis C ZeeCenter for Circadian and Sleep Medicine, Department of Neurology, Northwestern University, Chicago, Illinois.
Daniel R GangerNorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Comprehensive Transplant Center (CTC), Northwestern University, Chicago, Illinois.
Daniela P LadnerNorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Comprehensive Transplant Center (CTC), Northwestern University, Chicago, Illinois.
Ameeta KarmarkarDivision of Stroke and Neurocritical Care, Department of Neurology, Northwestern University, Chicago, Illinois.
John D PeipertNorthwestern University Transplant Outcomes Research Collaborative (NUTORC), Comprehensive Transplant Center (CTC), Northwestern University, Chicago, Illinois.
Farzaneh A SorondDivision of Stroke and Neurocritical Care, Department of Neurology, Northwestern University, Chicago, Illinois.
Shyam PrabhakaranDepartment of Neurology, University of Chicago, Chicago, Illinois.
Kathryn J ReidCenter for Circadian and Sleep Medicine, Department of Neurology, Northwestern University, Chicago, Illinois.
Andrew M NaidechDivision of Stroke and Neurocritical Care, Department of Neurology, Northwestern University, Chicago, Illinois.
Matthew B MaasDivision of Stroke and Neurocritical Care, Department of Neurology, Northwestern University, Chicago, Illinois.ORCID 0000-0003-1859-8357
Northwestern University · USUniversity of Chicago · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Northwestern University Clinical and Translational Science Institute (NUCATS)KL2TR001424 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SHARMA, LEENA · 2015 to 2023
$8.1M
Cerebral Small Vessels in Motor and Cognitive Decline: Neuroimaging Signatures of Vulnerability & ResilienceR01NS085002 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FARZANEH A SOROND · 2014 to 2026
$3.8M
Hemostasis, Hematoma Expansion, and Outcomes After Intracerebral HemorrhageR01NS110779 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI NAIDECH, ANDREW M · 2019 to 2023
$3.3M
Circadian Dysfunction, Encephalopathy, and Cognitive Outcomes after Critical IllnessK23NS092975 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MAAS, MATTHEW BRANDON · 2015 to 2019
$886k
NCATS NIH HHS KL2 TR001424NCATS NIH HHS UL1 TR001422NINDS NIH HHS K23 NS092975NINDS NIH HHS L30 NS080176NINDS NIH HHS L30 NS098427NINDS NIH HHS R01 NS085002NINDS NIH HHS R01 NS110779Northwestern University Feinberg School of Medicine
6 · The paper itself

Abstract

objectiveCognitive impairment, detected in up to 80% of patients with liver cirrhosis, is associated with negative health outcomes but is underdiagnosed in the clinical setting due to the lack of practical testing method. This single-center prospective observational study aimed to test the feasibility and prognostic utility of in-clinic cognitive assessment of patients with liver cirrhosis using the NIH Toolbox cognition battery (NIHTB).

methodsPatients recruited from a hepatology/transplant clinic underwent cognitive assessments using West-Haven Grade (WHG) and NIHTB between November 2016 and August 2018 and were prospectively followed until December 2018. The primary outcome was a composite end point of hospitalization related to overt hepatic encephalopathy (OHE) and all-cause mortality during follow-up, evaluated by a Cox proportional hazards regression model that adjusted for a priori covariates (age and MELD-Na).

resultsAmong 127 patients (median age 60 years, 48 [38%] women) assessed, cognitive performance was significantly impaired in 82 [78%] patients with WHG 0 and 22 [100%] patients with WHG 1 and 2. Over a median of 347 days follow-up, 18 OHE and 8 deaths were observed. Lower cognitive performance was associated with an increased risk of OHE/death adjusting for age and MELD-Na. Subclinical cognitive impairment detected by NIH Toolbox in WHG 0 patients was significantly associated with greater mortality. Median time to complete the two prognostically informative NIH Toolbox tests was 9.4 min.

interpretationNIH Toolbox may enable a rapid cognitive screening in the outpatient setting and identify patients at high risk for death and hospitalization for severe encephalopathy.

Indexed as

Neuropsychological TestsAgedCognitive DysfunctionFemaleHepatic EncephalopathyHospitalizationHumansLiver CirrhosisMaleMiddle AgedProspective StudiesRisk Factors

Identifiers

PMID31631586
PMCPMC6856598
OpenAlexW2981964832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.